Native mass spectrometry combined with enzymatic dissection unravels glycoform heterogeneity of biopharmaceuticals.
about
Native mass spectrometry combined with enzymatic dissection unravels glycoform heterogeneity of biopharmaceuticals.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Native mass spectrometry combi ...... geneity of biopharmaceuticals.
@en
Native mass spectrometry combi ...... geneity of biopharmaceuticals.
@nl
type
label
Native mass spectrometry combi ...... geneity of biopharmaceuticals.
@en
Native mass spectrometry combi ...... geneity of biopharmaceuticals.
@nl
prefLabel
Native mass spectrometry combi ...... geneity of biopharmaceuticals.
@en
Native mass spectrometry combi ...... geneity of biopharmaceuticals.
@nl
P2093
P2860
P50
P1476
Native mass spectrometry combi ...... ogeneity of biopharmaceuticals
@en
P2093
Eugen Damoc
Ines C Forstenlehner
Johann Holzmann
Kai Scheffler
Stefan Senn
P2860
P2888
P356
10.1038/S41467-018-04061-7
P407
P577
2018-04-30T00:00:00Z
P6179
1103685811